The discussion features insights from Dr. Heather Danks of LEX Diagnostics, Dr. Mike Broyles of Thermo Fisher Scientific, and QuidelOrtho’s own Dr. Lindy Carlstrom. Their conversation centers on moving laboratory-grade accuracy closer to the patient, specifically through ultra-fast RT-PCR technology capable of delivering respiratory test results in under ten minutes. By simplifying workflows, these advancements allow for molecular testing in near-patient and CLIA-waived settings, effectively reducing bottlenecks in hospital flow.

Beyond speed, the panel examines the role of procalcitonin (PCT) as a vital biomarker. Clinical implementation of PCT is linked to reduced antibiotic exposure and fewer hospital readmissions, offering a practical tool for stewardship. Similarly, the evolution of high-sensitivity troponin testing is reshaping cardiac care, enabling emergency departments to triage suspected cardiac events with greater precision. These innovations represent a shift toward immediate, actionable data, directly supporting the clinical goal of improved patient outcomes through faster intervention.